V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214420 | 20178216 | 1.66 | 68.1 | Palliative (P) | 2019-01-23 | 2019-02-07 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100626429 |
| 20214421 | 20178217 | 1.49 | 88 | Palliative (P) | 2019-07-28 | 2019-07-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101287588 |
| 20214422 | 20178218 | 1.63 | 93 | Palliative (P) | 2020-11-26 | 2020-12-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100625155 |
| 20214429 | 20178219 | 1.55 | 82.3 | null | 2020-09-13 | 2020-09-29 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101298321 |
| 20214442 | 20178220 | 1.68 | 113.4 | null | 2019-06-30 | 2019-08-03 | CAPECITABINE + GEMCITABINE | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100736970 |
| 20214458 | 20178221 | 1.63 | 77.8 | Palliative (P) | 2020-07-30 | 2020-07-30 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100411350 |
| 20214461 | 20178222 | null | 55.75 | Neo-adjuvant (N) | 2017-04-16 | 2017-04-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101848460 |
| 20214466 | 20178223 | 1.67 | 73.8 | Palliative (P) | 2021-07-25 | 2021-07-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100100404 |
| 20214468 | 20178224 | 1.88 | 42.8 | Palliative (P) | 2021-05-13 | 2021-05-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101508873 |
| 20214486 | 20178225 | 1.51 | 69 | Palliative (P) | 2019-05-11 | 2019-05-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101826337 |
| 20214494 | 20178226 | 1.49 | 86.5 | Palliative (P) | 2014-12-20 | 2016-12-05 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100208802 |
| 20214500 | 20178227 | 1.67 | 66.3 | Palliative (P) | 2020-08-20 | 2020-08-27 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101260767 |
| 20214543 | 20178228 | 1.7 | 67 | null | 2020-03-23 | 2020-04-06 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100411732 |
| 20214548 | 20178229 | 1.61 | 87.5 | Palliative (P) | 2017-11-11 | 2017-11-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100269889 |
| 20214568 | 20178230 | 1.6 | 71.4 | Palliative (P) | 2020-11-12 | 2020-11-18 | Docetaxel | 02 | N | DOCETAXEL | 101573049 |
| 20214570 | 20178231 | 1.67 | 59.8 | Palliative (P) | 2016-12-05 | 2016-12-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100236251 |
| 20214575 | 20178232 | 1.61 | 55 | null | 2021-05-29 | 2021-09-09 | Gemcitabine + Capecitabine | 01 | null | CAPECITABINE + GEMCITABINE | 101812671 |
| 20214583 | 20178233 | 1.66 | 71.8 | null | 2021-12-28 | 2022-05-05 | Docetaxel | 02 | null | DOCETAXEL | 101551641 |
| 20214586 | 20178234 | 1.7 | 96.3 | 03 | 2021-08-03 | 2022-03-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101070019 |
| 20214601 | 20178235 | 1.74 | 68 | null | 2018-10-05 | 2018-10-14 | Docetaxel | 02 | null | DOCETAXEL | 101834614 |
| 20214619 | 20178237 | 1.58 | 81.4 | Palliative (P) | 2018-01-02 | 2018-01-14 | Trastuzumab | 02 | N | TRASTUZUMAB | 100602166 |
| 20214624 | 20178238 | 1.82 | 123 | null | null | 2019-07-16 | CETUXIMAB | 02 | null | CETUXIMAB | 100666496 |
| 20214627 | 20178239 | 1.8 | 59.8 | Palliative (P) | null | 2019-12-19 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 101833304 |
| 20214639 | 20178240 | 1.75 | 73 | null | 2021-11-06 | 2021-11-09 | Trastuzumab | 02 | N | TRASTUZUMAB | 101060334 |
| 20214655 | 20178241 | 1.83 | 102.5 | Palliative (P) | 2019-11-07 | 2019-11-22 | Capecitabine + Cisplatin | null | N | CAPECITABINE + CISPLATIN | 101085675 |
| 20214659 | 20178242 | 1.83 | 72.7 | Palliative (P) | 2020-08-02 | 2020-08-23 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100013801 |
| 20214681 | 20178243 | 1.57 | 77.1 | Neo-adjuvant (N) | null | 2022-01-19 | TRASTUZUMAB | null | N | TRASTUZUMAB | 101226955 |
| 20214719 | 20178244 | 1.63 | 88.7 | Palliative (P) | 2018-03-05 | 2018-03-17 | Trastuzumab | 02 | N | TRASTUZUMAB | 100220145 |
| 20214747 | 20178245 | null | null | null | null | 2016-08-10 | CETUXIMAB | N | null | CETUXIMAB | 100230578 |
| 20214753 | 20178246 | 1.64 | 83.8 | Curative (C) | 2017-05-23 | 2017-06-28 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101057540 |
| 20214759 | 20178247 | 1.75 | 65.9 | Curative (C) | 2021-11-12 | 2021-11-14 | Capecitabine + Cisplatin | null | N | CAPECITABINE + CISPLATIN | 100127898 |
| 20214772 | 20178249 | 1.55 | 56.6 | Palliative (P) | 2021-09-18 | 2021-09-18 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100270949 |
| 20214822 | 20178251 | 1.51 | 50 | Neo-adjuvant (N) | 2022-01-18 | 2022-02-12 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 101704048 |
| 20214824 | 20178252 | 1.83 | 84.6 | null | 2021-09-22 | 2021-09-22 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 101510025 |
| 20214835 | 20178253 | 1.73 | 51.8 | null | 2019-10-29 | 2019-10-29 | Trastuzumab | 02 | null | CETUXIMAB | 101479784 |
| 20214839 | 20178254 | 1.74 | 53.1 | null | 2017-07-29 | 2017-09-10 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100794594 |
| 20214847 | 20178255 | 1.72 | 72.8 | Palliative (P) | 2019-05-25 | 2019-07-17 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101719580 |
| 20214852 | 20178256 | 1.61 | 78.8 | Palliative (P) | 2017-02-03 | 2017-02-03 | CETUXIMAB | 02 | N | CETUXIMAB | 101194972 |
| 20214891 | 20178257 | 1.77 | 76 | Palliative (P) | 2019-11-06 | 2019-11-19 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101751699 |
| 20214893 | 20178258 | 1.67 | 72.7 | null | 2017-02-19 | 2017-03-12 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100347945 |
| 20214909 | 20178259 | 1.51 | 91.5 | Palliative (P) | null | 2018-09-18 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100769305 |
| 20214976 | 20178260 | 1.87 | 117 | 02 | 2021-02-10 | 2021-03-01 | Trastuzumab | 02 | N | TRASTUZUMAB | 100942694 |
| 20214985 | 20178261 | 1.62 | 69.1 | null | 2019-11-12 | 2019-11-12 | Trastuzumab | 2 | null | TRASTUZUMAB | 101837086 |
| 20214995 | 20178262 | 1.62 | 93 | Palliative (P) | 2018-09-24 | 2018-10-02 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 101342111 |
| 20215007 | 20178263 | 1.58 | 66.9 | null | 2017-04-12 | 2017-05-31 | Trastuzumab 21 day loading dose | 02 | null | TRASTUZUMAB | 100540303 |
| 20215020 | 20178264 | 1.8 | 50 | Palliative (P) | 2021-07-27 | 2021-07-29 | CETUXIMAB | 02 | N | CETUXIMAB | 101439653 |
| 20215022 | 20178265 | 1.76 | 106 | null | 2020-12-08 | 2020-12-18 | CETUXIMAB | 02 | null | TRASTUZUMAB | 100813707 |
| 20215071 | 20178267 | 1.81 | null | Palliative (P) | 2019-12-21 | 2019-12-21 | Capecitabine + Cisplatin | 01 | N | CAPECITABINE + CISPLATIN | 101475060 |
| 20215076 | 20178268 | 1.59 | 75 | null | 2022-03-10 | 2022-03-22 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100048467 |
| 20215084 | 20178269 | 1.81 | 82 | Palliative (P) | 2019-08-26 | 2019-09-10 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100017471 |